BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18555871)

  • 1. [Which role of antineural autoantibodies in central nervous system diseases?].
    Honnorat J
    Rev Neurol (Paris); 2008 May; 164(5):403-4. PubMed ID: 18555871
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoantibody-mediated disorders of the central nervous system.
    Irani S; Lang B
    Autoimmunity; 2008 Feb; 41(1):55-65. PubMed ID: 18176865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase.
    Ishida K; Mitoma H; Song SY; Uchihara T; Inaba A; Eguchi S; Kobayashi T; Mizusawa H
    Ann Neurol; 1999 Aug; 46(2):263-7. PubMed ID: 10443895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia.
    Takenoshita H; Shizuka-Ikeda M; Mitoma H; Song S; Harigaya Y; Igeta Y; Yaguchi M; Ishida K; Shoji M; Tanaka M; Mizusawa H; Okamoto K
    J Neurol Neurosurg Psychiatry; 2001 Mar; 70(3):386-9. PubMed ID: 11181864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New autoantibody mediated disorders of the central nervous system.
    Lang B; Dale RC; Vincent A
    Curr Opin Neurol; 2003 Jun; 16(3):351-7. PubMed ID: 12858073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
    Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
    Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with immunotherapy in 3 patients with cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.
    Rouco I; Hurtado P; Castaño L; Zarranz JJ
    Neurologia; 2015 May; 30(4):247-9. PubMed ID: 24075582
    [No Abstract]   [Full Text] [Related]  

  • 8. Cerebellar ataxia with glutamic acid decarboxylase autoantibodies.
    Abele M; Weller M; Mescheriakov S; Bürk K; Dichgans J; Klockgether T
    Neurology; 1999 Mar; 52(4):857-9. PubMed ID: 10078741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective loss of Purkinje cells in a patient with anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia.
    Ishida K; Mitoma H; Wada Y; Oka T; Shibahara J; Saito Y; Murayama S; Mizusawa H
    J Neurol Neurosurg Psychiatry; 2007 Feb; 78(2):190-2. PubMed ID: 17119008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapidly progressing cerebellar ataxia associated with anti-GAD antibodies.
    Quintas S; Ruiz RL; Zapata-Wainberg G; Vivancos J
    Neurologia (Engl Ed); 2018 May; 33(4):273-275. PubMed ID: 27091680
    [No Abstract]   [Full Text] [Related]  

  • 11. The humoral response in the pathogenesis of gluten ataxia.
    Wiendl H; Mehling M; Dichgans J; Melms A; Bürk K
    Neurology; 2003 Apr; 60(8):1397; author reply 1397-9. PubMed ID: 12707460
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-GAD antibodies and periodic alternating nystagmus.
    Tilikete C; Vighetto A; Trouillas P; Honnorat J
    Arch Neurol; 2005 Aug; 62(8):1300-3. PubMed ID: 16087772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stiff, twitchy or wobbly: are GAD antibodies pathogenic?
    Vincent A
    Brain; 2008 Oct; 131(Pt 10):2536-7. PubMed ID: 18799517
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: CNS lupus: a study of 41 patients.
    Avalos Herrera E; Alvarez SY; Pacay CE
    Neurology; 2008 Apr; 70(18):1648; author reply 1648-9. PubMed ID: 18443320
    [No Abstract]   [Full Text] [Related]  

  • 15. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
    Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
    Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Steroid treatment in four cases of anti-GAD cerebellar ataxia].
    Bonnan M; Cabre P; Olindo S; Signate A; Saint-Vil M; Smadja D
    Rev Neurol (Paris); 2008 May; 164(5):427-33. PubMed ID: 18555874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebellar ataxia associated to anti-glutamic acid decarboxylase autoantibody (anti-GAD): partial improvement with intravenous immunoglobulin therapy.
    Pedroso JL; Braga-Neto P; Dutra LA; Barsottini OG
    Arq Neuropsiquiatr; 2011 Dec; 69(6):993. PubMed ID: 22297896
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of steroid treatment in cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.
    Virgilio R; Corti S; Agazzi P; Santoro D; Lanfranconi S; Candelise L; Bresolin N; Comi GP; Bersano A
    J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):95-6. PubMed ID: 19091718
    [No Abstract]   [Full Text] [Related]  

  • 19. Cerebellar ataxia and nystagmus with GAD antibodies in a woman from the West Indies : a video demonstration.
    Ramcharan K; Reyes AJ; Abdool K; Raamkaransingh N
    BMJ Case Rep; 2019 Oct; 12(10):. PubMed ID: 31615777
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serological indicators in systemic lupus of the central nervous system].
    Avinoach I; Teplizki H; Shoenfeld Y
    Harefuah; 1988 Apr; 114(8):387-90. PubMed ID: 3063624
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.